A citation-based method for searching scientific literature

Xose S Puente, Silvia Beà, Rafael Valdés-Mas, Neus Villamor, Jesús Gutiérrez-Abril, José I Martín-Subero, Marta Munar, Carlota Rubio-Pérez, Pedro Jares, Marta Aymerich, Tycho Baumann, Renée Beekman, Laura Belver, Anna Carrio, Giancarlo Castellano, Guillem Clot, Enrique Colado, Dolors Colomer, Dolors Costa, Julio Delgado, Anna Enjuanes, Xavier Estivill, Adolfo A Ferrando, Josep L Gelpí, Blanca González, Santiago González, Marcos González, Marta Gut, Jesús M Hernández-Rivas, Mónica López-Guerra, David Martín-García, Alba Navarro, Pilar Nicolás, Modesto Orozco, Ángel R Payer, Magda Pinyol, David G Pisano, Diana A Puente, Ana C Queirós, Víctor Quesada, Carlos M Romeo-Casabona, Cristina Royo, Romina Royo, María Rozman, Nuria Russiñol, Itziar Salaverría, Kostas Stamatopoulos, Hendrik G Stunnenberg, David Tamborero, María J Terol, Alfonso Valencia, Nuria López-Bigas, David Torrents, Ivo Gut, Armando López-Guillermo, Carlos López-Otín, Elías Campo. Nature 2015
Times Cited: 526







List of co-cited articles
992 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mutations driving CLL and their evolution in progression and relapse.
Dan A Landau, Eugen Tausch, Amaro N Taylor-Weiner, Chip Stewart, Johannes G Reiter, Jasmin Bahlo, Sandra Kluth, Ivana Bozic, Mike Lawrence, Sebastian Böttcher,[...]. Nature 2015
595
42

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.
Xose S Puente, Magda Pinyol, Víctor Quesada, Laura Conde, Gonzalo R Ordóñez, Neus Villamor, Georgia Escaramis, Pedro Jares, Sílvia Beà, Marcos González-Díaz,[...]. Nature 2011
24

Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner, S Stilgenbauer, A Benner, E Leupolt, A Kröber, L Bullinger, K Döhner, M Bentz, P Lichter. N Engl J Med 2000
22

Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.
Dan A Landau, Scott L Carter, Petar Stojanov, Aaron McKenna, Kristen Stevenson, Michael S Lawrence, Carrie Sougnez, Chip Stewart, Andrey Sivachenko, Lili Wang,[...]. Cell 2013
944
20

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.
Michael Hallek, Bruce D Cheson, Daniel Catovsky, Federico Caligaris-Cappio, Guillermo Dighiero, Hartmut Döhner, Peter Hillmen, Michael Keating, Emili Montserrat, Nicholas Chiorazzi,[...]. Blood 2018
551
20

Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial.
Stephan Stilgenbauer, Andrea Schnaiter, Peter Paschka, Thorsten Zenz, Marianna Rossi, Konstanze Döhner, Andreas Bühler, Sebastian Böttcher, Matthias Ritgen, Michael Kneba,[...]. Blood 2014
340
19

Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.
Giulia Fabbri, Silvia Rasi, Davide Rossi, Vladimir Trifonov, Hossein Khiabanian, Jing Ma, Adina Grunn, Marco Fangazio, Daniela Capello, Sara Monti,[...]. J Exp Med 2011
442
17

Recurrent mutations refine prognosis in chronic lymphocytic leukemia.
P Baliakas, A Hadzidimitriou, L-A Sutton, D Rossi, E Minga, N Villamor, M Larrayoz, J Kminkova, A Agathangelidis, Z Davis,[...]. Leukemia 2015
210
16

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Steven H Swerdlow, Elias Campo, Stefano A Pileri, Nancy Lee Harris, Harald Stein, Reiner Siebert, Ranjana Advani, Michele Ghielmini, Gilles A Salles, Andrew D Zelenetz,[...]. Blood 2016
16

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.
Ferran Nadeu, Julio Delgado, Cristina Royo, Tycho Baumann, Tatjana Stankovic, Magda Pinyol, Pedro Jares, Alba Navarro, David Martín-García, Sílvia Beà,[...]. Blood 2016
184
15

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.
Davide Rossi, Silvia Rasi, Giulia Fabbri, Valeria Spina, Marco Fangazio, Francesco Forconi, Roberto Marasca, Luca Laurenti, Alessio Bruscaggin, Michaela Cerri,[...]. Blood 2012
315
14

Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia.
F Nadeu, G Clot, J Delgado, D Martín-García, T Baumann, I Salaverria, S Beà, M Pinyol, P Jares, A Navarro,[...]. Leukemia 2018
60
21

Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.
T J Hamblin, Z Davis, A Gardiner, D G Oscier, F K Stevenson. Blood 1999
13

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Roland Schmitz, George W Wright, Da Wei Huang, Calvin A Johnson, James D Phelan, James Q Wang, Sandrine Roulland, Monica Kasbekar, Ryan M Young, Arthur L Shaffer,[...]. N Engl J Med 2018
716
12

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.
Víctor Quesada, Laura Conde, Neus Villamor, Gonzalo R Ordóñez, Pedro Jares, Laia Bassaganyas, Andrew J Ramsay, Sílvia Beà, Magda Pinyol, Alejandra Martínez-Trillos,[...]. Nat Genet 2011
708
11

Signatures of mutational processes in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Samuel A J R Aparicio, Sam Behjati, Andrew V Biankin, Graham R Bignell, Niccolò Bolli, Ake Borg, Anne-Lise Børresen-Dale,[...]. Nature 2013
11

SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.
Lili Wang, Michael S Lawrence, Youzhong Wan, Petar Stojanov, Carrie Sougnez, Kristen Stevenson, Lillian Werner, Andrey Sivachenko, David S DeLuca, Li Zhang,[...]. N Engl J Med 2011
784
11

Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.
R N Damle, T Wasil, F Fais, F Ghiotto, A Valetto, S L Allen, A Buchbinder, D Budman, K Dittmar, J Kolitz,[...]. Blood 1999
11

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.
Panagiotis Baliakas, Sabine Jeromin, Michalis Iskas, Anna Puiggros, Karla Plevova, Florence Nguyen-Khac, Zadie Davis, Gian Matteo Rigolin, Andrea Visentin, Aliki Xochelli,[...]. Blood 2019
82
13

Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia.
Davide Rossi, Silvia Rasi, Valeria Spina, Alessio Bruscaggin, Sara Monti, Carmela Ciardullo, Clara Deambrogi, Hossein Khiabanian, Roberto Serra, Francesco Bertoni,[...]. Blood 2013
325
10

Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.
Jennifer A Woyach, Richard R Furman, Ta-Ming Liu, Hatice Gulcin Ozer, Marc Zapatka, Amy S Ruppert, Ling Xue, Daniel Hsieh-Hsin Li, Susanne M Steggerda, Matthias Versele,[...]. N Engl J Med 2014
750
10

The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia.
Renée Beekman, Vicente Chapaprieta, Núria Russiñol, Roser Vilarrasa-Blasi, Núria Verdaguer-Dot, Joost H A Martens, Martí Duran-Ferrer, Marta Kulis, François Serra, Biola M Javierre,[...]. Nat Med 2018
89
11

Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution.
S Kasar, J Kim, R Improgo, G Tiao, P Polak, N Haradhvala, M S Lawrence, A Kiezun, S M Fernandes, S Bahl,[...]. Nat Commun 2015
123
9

NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL.
Ilaria Del Giudice, Davide Rossi, Sabina Chiaretti, Marilisa Marinelli, Simona Tavolaro, Sara Gabrielli, Luca Laurenti, Roberto Marasca, Silvia Rasi, Marco Fangazio,[...]. Haematologica 2012
143
9

Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.
Davide Rossi, Marco Fangazio, Silvia Rasi, Tiziana Vaisitti, Sara Monti, Stefania Cresta, Sabina Chiaretti, Ilaria Del Giudice, Giulia Fabbri, Alessio Bruscaggin,[...]. Blood 2012
217
9

The repertoire of mutational signatures in human cancer.
Ludmil B Alexandrov, Jaegil Kim, Nicholas J Haradhvala, Mi Ni Huang, Alvin Wei Tian Ng, Yang Wu, Arnoud Boot, Kyle R Covington, Dmitry A Gordenin, Erik N Bergstrom,[...]. Nature 2020
740
9

Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens.
Philip A Thompson, Susan M O'Brien, William G Wierda, Alessandra Ferrajoli, Francesco Stingo, Susan C Smith, Jan A Burger, Zeev Estrov, Nitin Jain, Hagop M Kantarjian,[...]. Cancer 2015
170
9

BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia.
Jennifer A Woyach, Amy S Ruppert, Daphne Guinn, Amy Lehman, James S Blachly, Arletta Lozanski, Nyla A Heerema, Weiqiang Zhao, Joshua Coleman, Daniel Jones,[...]. J Clin Oncol 2017
233
9

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.
Esther Rheinbay, Morten Muhlig Nielsen, Federico Abascal, Jeremiah A Wala, Ofer Shapira, Grace Tiao, Henrik Hornshøj, Julian M Hess, Randi Istrup Juul, Ziao Lin,[...]. Nature 2020
189
9


Mutational heterogeneity in cancer and the search for new cancer-associated genes.
Michael S Lawrence, Petar Stojanov, Paz Polak, Gregory V Kryukov, Kristian Cibulskis, Andrey Sivachenko, Scott L Carter, Chip Stewart, Craig H Mermel, Steven A Roberts,[...]. Nature 2013
8

Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.
Andrew W Roberts, Matthew S Davids, John M Pagel, Brad S Kahl, Soham D Puvvada, John F Gerecitano, Thomas J Kipps, Mary Ann Anderson, Jennifer R Brown, Lori Gressick,[...]. N Engl J Med 2016
8

Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.
Inhye E Ahn, Chingiz Underbayev, Adam Albitar, Sarah E M Herman, Xin Tian, Irina Maric, Diane C Arthur, Laura Wake, Stefania Pittaluga, Constance M Yuan,[...]. Blood 2017
186
8

The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.
Davide Rossi, Vladimir Trifonov, Marco Fangazio, Alessio Bruscaggin, Silvia Rasi, Valeria Spina, Sara Monti, Tiziana Vaisitti, Francesca Arruga, Rosella Famà,[...]. J Exp Med 2012
256
8

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Bjoern Chapuy, Chip Stewart, Andrew J Dunford, Jaegil Kim, Atanas Kamburov, Robert A Redd, Mike S Lawrence, Margaretha G M Roemer, Amy J Li, Marita Ziepert,[...]. Nat Med 2018
616
8

The molecular pathogenesis of chronic lymphocytic leukaemia.
Giulia Fabbri, Riccardo Dalla-Favera. Nat Rev Cancer 2016
157
8

Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study.
Arnon P Kater, Jenny Qun Wu, Thomas Kipps, Barbara Eichhorst, Peter Hillmen, James D'Rozario, Sarit Assouline, Carolyn Owen, Tadeusz Robak, Javier de la Serna,[...]. J Clin Oncol 2020
70
11

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
Jennifer A Woyach, Amy S Ruppert, Nyla A Heerema, Weiqiang Zhao, Allison M Booth, Wei Ding, Nancy L Bartlett, Danielle M Brander, Paul M Barr, Kerry A Rogers,[...]. N Engl J Med 2018
413
8

Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience.
Susan O'Brien, Richard R Furman, Steven Coutre, Ian W Flinn, Jan A Burger, Kristie Blum, Jeff Sharman, William Wierda, Jeffrey Jones, Weiqiang Zhao,[...]. Blood 2018
253
8

Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.
Tait D Shanafelt, Xin V Wang, Neil E Kay, Curtis A Hanson, Susan O'Brien, Jacqueline Barrientos, Diane F Jelinek, Esteban Braggio, Jose F Leis, Cong C Zhang,[...]. N Engl J Med 2019
300
8

Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center study.
Alexander C Leeksma, Panagiotis Baliakas, Theodoros Moysiadis, Anna Puiggros, Karla Plevova, Anne-Marie Van der Kevie-Kersemaekers, Hidde Posthuma, Ana E Rodriguez-Vicente, Anh Nhi Tran, Gisela Barbany,[...]. Haematologica 2021
22
36

Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia.
Marta Kulis, Simon Heath, Marina Bibikova, Ana C Queirós, Alba Navarro, Guillem Clot, Alejandra Martínez-Trillos, Giancarlo Castellano, Isabelle Brun-Heath, Magda Pinyol,[...]. Nat Genet 2012
385
7

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.
M Hallek, K Fischer, G Fingerle-Rowson, A M Fink, R Busch, J Mayer, M Hensel, G Hopfinger, G Hess, U von Grünhagen,[...]. Lancet 2010
7

Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome.
Giulia Fabbri, Hossein Khiabanian, Antony B Holmes, Jiguang Wang, Monica Messina, Charles G Mullighan, Laura Pasqualucci, Raul Rabadan, Riccardo Dalla-Favera. J Exp Med 2013
174
7

NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation.
F Pozzo, T Bittolo, F Arruga, P Bulian, P Macor, E Tissino, B Gizdic, F M Rossi, R Bomben, A Zucchetto,[...]. Leukemia 2016
55
12


Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.
Richard R Furman, Jeff P Sharman, Steven E Coutre, Bruce D Cheson, John M Pagel, Peter Hillmen, Jacqueline C Barrientos, Andrew D Zelenetz, Thomas J Kipps, Ian Flinn,[...]. N Engl J Med 2014
7

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.
John C Byrd, Richard R Furman, Steven E Coutre, Ian W Flinn, Jan A Burger, Kristie A Blum, Barbara Grant, Jeff P Sharman, Morton Coleman, William G Wierda,[...]. N Engl J Med 2013
7

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.
J Malcikova, E Tausch, D Rossi, L A Sutton, T Soussi, T Zenz, A P Kater, C U Niemann, D Gonzalez, F Davi,[...]. Leukemia 2018
91
7

TP53 mutation and survival in chronic lymphocytic leukemia.
Thorsten Zenz, Barbara Eichhorst, Raymonde Busch, Tina Denzel, Sonja Häbe, Dirk Winkler, Andreas Bühler, Jennifer Edelmann, Manuela Bergmann, Georg Hopfinger,[...]. J Clin Oncol 2010
387
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.